Stochastic kinetics of intracellular huntingtin aggregate formation

Nature Chemical Biology

Volumn 2, Issue 6, 2006, Pages 319-323

  Colby, David W ^a   Cassady, John P ^b   Lin, Grace C ^b   Ingram, Vernon M ^b   Wittrup, K Dane ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; PEPTIDE; POLYGLUTAMINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; FLUORESCENCE; HUNTINGTON CHOREA; IN VITRO SELECTION; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STOCHASTIC MODEL;

ANIMALIA;

EID: 33646884427     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio792     Document Type: Article

References (38)

1. Clarke, G. et al. A one-hit model of cell death in inherited neuronal degenerations. Nature 406, 195-199 (2000).
2. Perutz, M.F. & Windle, A.H. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats. Nature 412, 143-144 (2001).
3. Chen, S., Ferrone, F.A. & Wetzel, R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA 99, 11884-11889 (2002).
4. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993 (1997).
5. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810 (2004).
6. Bence, N.F., Sampat, R.M. & Kopito, R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555 (2001).
7. Garcia, M., Charvin, D. & Caboche, J. Expanded huntingtin activates the c-Jun terminal kinase/c-Jun pathway prior to aggregate formation in striatal neurons in culture. Neuroscience 127, 859-870 (2004).
8. Meriin, A.B. et al. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 157, 997-1004 (2002).
9. Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66 (1998).
10. Nucifora, F.C., Jr. et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428 (2001).
11. Lomakin, A., Teplow, D.B., Kirschner, D.A. & Benedek, G.B. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. USA 94, 7942-7947 (1997).
12. Gillespie, D.T. Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 81, 2340-2361 (1977).
13. Hofrichter, J., Ross, P.D. & Eaton, W.A. Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc. Natl. Acad. Sci. USA 71, 4864-4868 (1974).
14. Jarrett, J.T. & Lansbury, P.T., Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058 (1993).
15. Cattaneo, E. & Conti, L. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J. Neurosci. Res. 53, 223-234 (1998).
16. Arrasate, M. & Finkbeiner, S. Automated microscope system for determining factors that predict neuronal fate. Proc. Natl. Acad. Sci. USA 102, 3840-3845 (2005).
17. Renshaw, E. Modelling Biological Populations in Space and Time (Cambridge University Press, Cambridge, UK, 1991).
18. Szabo, A. Fluctuations in the polymerization of sickle hemoglobin. A simple analytic model. J. Mol. Biol. 199, 539-542 (1988).
19. Cao, Z. & Ferrone, F.A. Homogeneous nucleation in sickle hemoglobin: stochastic measurements with a parallel method. Biophys. J. 72, 343-352 (1997).
20. Bhattacharyya, A.M., Thakur, A.K. & Wetzel, R. Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc. Natl. Acad. Sci. USA 102, 15400-15405 (2005).
21. Shtilerman, M.D., Ding, T.T. & Lansbury, P.T., Jr. Molecular crowding accelerates fibrillization of α-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41, 3855-3860 (2002).
22. Hatters, D.M., Minton, A.P. & Howlett, G.J. Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II. J. Biol. Chem. 277, 7824-7830 (2002).
23. Ivanova, M., Jasuja, R., Kwong, S., Briehl, R.W. & Ferrone, F.A. Nonideality and the nucleation of sickle hemoglobin. Biophys. J. 79, 1016-1022 (2000).
24. Minton, A.P. The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J. Biol. Chem. 276, 10577-10580 (2001).
25. Slow, E.J. et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc. Natl. Acad. Sci. USA 102, 11402-11407 (2005).
26. Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558 (1997).
27. Zhang, X. et al. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. Proc. Natl. Acad. Sci. USA 102, 892-897 (2005).
28. Kazantsev, A. et al. A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nat. Genet. 30, 367-376 (2002).
29. Colby, D.W. et al. Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Proc. Natl. Acad. Sci. USA 101, 17616-17621 (2004).
30. Gu, X. et al. Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46, 433-444 (2005).
31. Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820-5825 (2005).
32. Nance, M.A. & Myers, R.H. Juvenile onset Huntington's disease - clinical and research perspectives. Ment. Retard. Dev. Disabil. Res. Rev. 7, 153-157 (2001).
33. Gusella, J.F. & MacDonald, M.E. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 1, 109-115 (2000).
34. Wexler, N.S. et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. USA 101, 3498-3503 (2004).
35. Squitieri, F. et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126, 946-955 (2003).
36. Krobitsch, S. & Lindquist, S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. USA 97, 1589-1594 (2000).
37. Larson, H.J. Introduction to Probability Theory and Statistical Inference (Wiley, New York, 1982).
38. nd edn. http://www.hdsa.org/site/DocServer/Physicians_Guide_JAT_conversion_color_5-4-05. pdf?docID-241 (Huntington's Disease Society of America, New York, 1999).